Urinary retention and sympathetic sphincter obstruction in axonal Guillain-Barré syndrome

Muscle Nerve. 2007 Jan;35(1):111-5. doi: 10.1002/mus.20639.

Abstract

A 62-year-old woman with axonal Guillain-Barré syndrome developed weakness and urinary retention simultaneously. The retention failed to recover for 10 months even after she regained the ability to walk. The patient exhibited no postural hypotension. Videourodynamics showed that the retention was caused not by the bladder paralysis but rather by internal (sympathetic) sphincter obstruction, which is extremely uncommon in peripheral neuropathies. We started the patient on an alpha-adrenergic antagonist, urapidil, at 30 mg/day, and this led to successful relaxation of the urethra and reduced the postvoid residual from 200 ml to less than 30 ml. The underlying mechanisms of urinary retention in our patient appeared to involve hyperactive lumbosacral sympathetic nerves. Urinary retention and sympathetic sphincter obstruction can thus be features of axonal Guillain-Barré syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use
  • Autonomic Nervous System Diseases / drug therapy
  • Autonomic Nervous System Diseases / etiology
  • Autonomic Nervous System Diseases / physiopathology*
  • Female
  • Guillain-Barre Syndrome / complications
  • Guillain-Barre Syndrome / physiopathology*
  • Humans
  • Hypogastric Plexus / drug effects
  • Hypogastric Plexus / physiopathology
  • Middle Aged
  • Muscle Hypertonia / drug therapy
  • Muscle Hypertonia / etiology
  • Muscle Hypertonia / physiopathology*
  • Muscle, Smooth / innervation
  • Muscle, Smooth / physiopathology
  • Piperazines / therapeutic use
  • Sympathetic Fibers, Postganglionic / drug effects
  • Sympathetic Fibers, Postganglionic / physiopathology*
  • Treatment Outcome
  • Urinary Bladder / innervation
  • Urinary Bladder / physiopathology*
  • Urination Disorders / drug therapy
  • Urination Disorders / etiology
  • Urination Disorders / physiopathology*

Substances

  • Adrenergic alpha-Antagonists
  • Piperazines
  • urapidil